FREDDA JACKSON: Open Payments
NPI 1487968012 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 26 payments from 7 companies in 2025. Trend: 2023 $345 · 2024 $419 · 2025 $547
Food & beverage: $547
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 4 | $201 |
| E.R. Squibb & Sons, L.L.C. | 14 | $197 |
| Neurocrine BioSciences, Inc. | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
| Almatica Pharma LLC | 1 | $22 |
| Alkermes, Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
Products named: Qelbree, COBENFY, INGREZZA, REXULTI, LOREEV XR, LYBALVI, UZEDY.
Industry payments across NJ — which companies pay providers there.
